PATENT CLAIM ANALYSIS

Application Number: 16333916
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-07
Patent Classification: ["424", "093210"]

Abstract:
Production of a chimeric antigen receptor (CAR) expressing cell having excellent target cytotoxicity. Provided is a genetically modified cell comprising, introduced thereinto, a polynucleotide encoding a chimeric antigen receptor (CAR) protein having a target binding domain that specifically binds to a human granulocyte-macrophage colony stimulating factor (GM-CSF) receptor, a transmembrane domain and an intracellular signaling domain.

Claim (Index 4):
The cell according to  claim 1 , wherein the CAR protein further comprises a co-stimulatory domain and/or an extracellular spacer domain.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 99.0
- Lexical Diversity: 1.52273
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15475681', '15897743', '15511973', '15258887', '15685670']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7564477725873278
- 35 USC 102 Novelty (BERT): 0.5235087480646583
- Combined Prediction Score: 0.7331538701350608
- Mean Citation Score: 303.68119
- Max Citation Score: 315.94635
- Similarity Product: 207.60935157410503

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test